Logo

Illumina Completes GenoLogics Acquisition

Sep 01, 2015 | staff reporter

NEW YORK (GenomeWeb) – Illumina today announced it has completed the acquisition of laboratory information management systems (LIMS) software developer GenoLogics.

The firm announced it would buy Victoria, British Columbia-based GenoLogics in early August for an undisclosed amount.

"Adopted by more than 120 genomic labs worldwide, GenoLogics' Clarity LIMS software strengthens our industry-leading portfolio of genetic analysis solutions," Illumina President Francis deSouza said in a statement.

In September 2014, Illumina selected Clarity as its preferred LIMS for the HiSeq X Ten sequencing platform.

Filed under

Business News
Informatics
asset acquisition
LIMS
Illumina
Breaking News
The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.